Parallax Volatility Advisers
BLUE

Parallax Volatility Advisers’s bluebird bio BLUE Stock Holding History

Parallax Volatility Advisers’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-401
Closed -$516K – 2799
2018
Q4 		$516K Buy
401
+15
+4% +$23K ﹤0.01% 1494
2018
Q3 		$730K Hold
386
– – ﹤0.01% 1359
2018
Q2 		$785K Buy
+386
New +$880K ﹤0.01% 1154

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Parallax Volatility Advisers's BLUE Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 12 shares — an estimated $20K sold.

Parallax Volatility Advisers first reported a position in BLUE in Q4 2017 and held it in 7 quarters. The position peaked at $1.33M in Q4 2017. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 12 bluebird bio shares in Q3 2019, an estimated $20K.
  • Parallax Volatility Advisers first reported a position in bluebird bio in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's bluebird bio position peaked at $1.33M in Q4 2017.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.